Almost the entire board of directors of Novo Nordisk is resigning after a conflict with the company's major owner, the Novo Nordisk Foundation, over the future composition of the board. Among those leaving is Chairman Helge Lund.
You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.